ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

National Coalition An Education Group, Chairman Says

May 3, 1985

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

December 9, 1994

Murphy Puts RPMI On Record

July 22, 1977

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011